This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nutrition & Biosciences USA 4, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Inventor Kyle Kim
Introduction
Kyle Kim is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of biosciences, particularly through his innovative work on graft copolymers. His research focuses on the development of new materials that have various applications in the industry.
Latest Patents
Kyle Kim holds a patent for "Dextran-alpha-glucan graft copolymers and derivatives thereof." This patent discloses compositions that comprise at least one alpha-glucan graft copolymer derivative compound, such as ether or ester, with a degree of substitution (DoS) of up to about 3.0. The precursors of these derivative compounds are graft copolymers that feature a dextran backbone and alpha-glucan side chains. Notably, at least about 30% of the glycosidic linkages of the alpha-glucan side chains are alpha-1,3 glycosidic linkages. The patent also outlines methods for producing these graft copolymer derivatives and their potential uses in various applications and products. Kyle Kim has 1 patent to his name.
Career Highlights
Kyle Kim is currently employed at Nutrition & Biosciences USA 4, Inc., where he continues to innovate and develop new materials. His work is instrumental in advancing the field of biosciences and enhancing product formulations.
Collaborations
Kyle collaborates with talented professionals in his field, including Douglas J. Adelman and Natnael Behabtu. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Kyle Kim is a notable inventor whose work on graft copolymers has the potential to impact various industries. His innovative approach and dedication to research continue to drive advancements in biosciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
